A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
Purdue Biologist Stanton B. Gelvin explained how Agrobacterium moves DNA into wounded plant cells, and why cracking that “black box” matters for agriculture during a seminar Wednesday afternoon at the ...
Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR ...
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Axios on MSN
FDA smooths reviews of rare disease treatments
The Food and Drug Administration on Monday laid out a new pathway aimed at spurring novel individualized treatments targeting ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results